Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Ronald Beaney"'
Autor:
Amen Sibtain, Hannah C P Wilson, Patricia M Price, Christy Goldsmith, Andrew Edwards, Rhiannon Davies, Keyoumars Ashkan, Ronald Beaney, Timothy Cross, Nick P Plowman, Melanie M Green
Publikováno v:
Cureus
The study aim was to evaluate patient individualized Cyberknife® treatment for heterogeneous skull-base tumors. Patients treated between 2009 and 2013 at The Harley Street Clinic were studied. In total, 66 patients received 15–30 Gy in 1–5 fract
Autor:
Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson, Jian Campian, Lawrence Recht, Samuel Goldlust, Kevin Becker, Gene Barnett, Garth Nicholas, Annick Desjardins, Tara Benkers, Naveed Wagle, Morris Groves, Santosh Kesari, Zsolt Horvath, Ryan Merrell, Richard Curry, James O'Rourke, David Schuster, Maciej Mrugala, Randy Jensen, John Trusheim, Glenn Lesser, Karl Belanger, Andrew Sloan, Benjamin Purow, Karen Fink, Jeffrey Raizer, Michael Schulder, Suresh Nair, Scott Peak, Alba Brandes, Nimish Mohile, Joseph Landolfi, Jon Olson, Ross Jennens, Paul DeSouza, Bridget Robinson, Marka Crittenden, Kent Shih, Alexandra Flowers, Shirley Ong, Jennifer Connelly, Costas Hadjipanayis, Pierre Giglio, Frank Mott, David Mathieu, Nathalie Lessard, Sanchez Juan Sepulveda, József Lövey, Helen Wheeler, Po-Ling Inglis, Claire Hardie, Daniela Bota, Maciej Lesniak, Jana Portnow, Bruce Frankel, Larry Junck, Reid Thompson, Lawrence Berk, John McGhie, David Macdonald, Frank Saran, Riccardo Soffietti, Deborah Blumenthal, Sá Barreto Costa Marcos André de, Anna Nowak, Nimit Singhal, Andreas Hottinger, Andrea Schmid, Gordan Srkalovic, David Baskin, Camilo Fadul, Louis Nabors, Renato LaRocca, John Villano, Nina Paleologos, Petr Kavan, Marshall Pitz, Brian Thiessen, Ahmed Idbaih, Jean Sébastien Frenel, Julien Domont, Oliver Grauer, Peter Hau, Christine Marosi, Jan Sroubek, Elizabeth Hovey, P.S. Sridhar, Lawrence Cher, Erin Dunbar, Thomas Coyle, Jane Raymond, Kevin Barton, Michael Guarino, Sumul Raval, Baldassarre Stea, Jorge Dietrich, Kirsten Hopkins, Sara Erridge, Joachim-Peter Steinbach, Losada Estela Pineda, Quintero Carmen Balana, Barco Berron Sonia del, Miklós Wenczl, Katalin Molnár, Katalin Hideghéty, Alexander Lossos, Linde Myra van, Ana Levy, Rosemary Harrup, William Patterson, Zarnie Lwin, Sith Sathornsumetee, E-Jian Lee, Jih-Tsun Ho, Steven Emmons, J. Paul Duic, Spencer Shao, Hani Ashamalla, Michael Weaver, Jose Lutzky, Nicholas Avgeropoulos, Wahid Hanna, Mukund Nadipuram, Gary Cecchi, Robert O'Donnell, Susan Pannullo, Jennifer Carney, Mark Hamilton, Mary MacNeil, Ronald Beaney, Michel Fabbro, Oliver Schnell, Rainer Fietkau, Guenther Stockhammer, Bela Malinova, Karel Odrazka, Martin Sames, Gil Miguel Gil, Evangelia Razis, Konstantin Lavrenkov, Guillermo Castro, Francisco Ramirez, Clarissa Baldotto, Fabiana Viola, Suzana Malheiros, Jason Lickliter, Stanislaw Gauden, Arunee Dechaphunkul, Iyavut Thaipisuttikul, Ziad Thotathil, Hsin-I Ma, Wen-Yu Cheng, Chin-Hong Chang, Fernando Salas, Pierre-Yves Dietrich, Christoph Mamot, Lakshmi Nayak, Shona Nag
Publikováno v:
The Lancet Oncology, Vol. 18, No 10 (2017) pp. 1373-1385
The Lancet. Oncology, vol 18, iss 10
The Lancet. Oncology, vol 18, iss 10
Summary Background Rindopepimut (also known as CDX-110), a vaccine targeting the EGFR deletion mutation EGFRvIII, consists of an EGFRvIII-specific peptide conjugated to keyhole limpet haemocyanin. In the ACT IV study, we aimed to assess whether or no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6b5ae20a38597b1d233965368e0708
https://doi.org/10.5167/uzh-141081
https://doi.org/10.5167/uzh-141081
Publikováno v:
Cancer Treatment Reviews. 40:48-59
Chemotherapy has made substantial progress in the therapy of systemic cancer, but the phar-macological efficacy is insufficient in the treatment of brain metastases. Fractionated whole brain radiotherapy (WBRT) has been a standard treatment of brain
Autor:
Alison Cameron, Jacqueline Bromberg, Antonio Silvani, Matthias Preusser, Thierry Gorlia, Michael Weller, Elodie Vauleon, Ronald Beaney, Christine Marosi, Wolfgang Wick, Sara Erridge, Giuseppe Lombardi, Emilie Le Rhun, Petter Brandal, Riccardo Soffietti, Juan Manuel Sepúlveda, Veronique Lorgis, Alice Bonneville-Levard, Vassilis Golfinopoulos
Publikováno v:
Journal of Clinical Oncology. 37:2007-2007
2007 Background: EORTC-1320-BTG investigated the activity, safety and quality of life of therapy with the tetrahydroisoquinoline alkaloid trabectedin (Yondelis) in patients with recurrent higher-grade meningiomas. Trabectedin was originally derived f
Publikováno v:
Pituitary
The BRAF V600E mutation has recently been identified in a high percentage of papillary craniopharyngiomas [1, 2]. The V600E mutation constitutively activates the MEK-ERK pathway, and the mutation-specific BRAF inhibitor vemurafenib, which targets mut
Autor:
Victoria Hurwitz, Keyoumars Ashkan, Angela Swampillai, Lucy Brazil, Laura Mullens, Ranj Bhangoo, Ronald Beaney, Priyanka Patel
Publikováno v:
Neuro-Oncology. 20:v361-v361
Glioblastoma diagnosis carries a poor prognosis. A combination of surgical resection and chemo-radiotherapy is the current standard of care with median survival rates of 15 months. A 33 year old lady, pregnant at 26 + 3 weeks gestation presented with
Autor:
Liz Ford, Angela Swampillai, Laura Mullens, Rob Urwin, Keyoumars Ashkan, Jess La, Ranj Bhangoo, Jillian Maccoll, Ronald Beaney, Richard Gullan, Vicky Hurwitz, Francesco Vergani, Lucy Brazil
Publikováno v:
Neuro-Oncology. 20:i18-i18
Autor:
Louis Potters, Ronald Beaney, Rick Popert, Janette Nichol, Ursula H. Johnson, Peter Acher, Susan L. Austin-Smith, S L Morris
Publikováno v:
BJU International. 99:1066-1071
To compare the quality of permanent prostate brachytherapy (PPB) implants, dosimetric outcomes and urinary morbidity between patients with large (50 mL) and those with smaller prostates, treated with a dynamic dose-feedback technique as monotherapy f
Autor:
Stephen Morris, Ronald Beaney, Aine Goggins, Ben Challacombe, Peter Acher, Rick Popert, Hidekazu Yamamoto
Publikováno v:
Journal of Urology. 193
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 65:694-698
Purpose: A permanent prostate brachytherapy (PPB) program utilizing intraoperative inverse-planned dynamic dose-feedback was initiated without prior firsthand experience of alternative techniques. The purpose of this study is to assess the dosimetric